These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 27760780
1. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis. Eby JC, Gray MC, Warfel JM, Merkel TJ, Hewlett EL. Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780 [Abstract] [Full Text] [Related]
2. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Cherry JD, Xing DX, Newland P, Patel K, Heininger U, Corbel MJ. Clin Infect Dis; 2004 Feb 15; 38(4):502-7. PubMed ID: 14765342 [Abstract] [Full Text] [Related]
3. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J. Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718 [Abstract] [Full Text] [Related]
4. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis. DiVenere AM, Amengor D, Silva RP, Goldsmith JA, McLellan JS, Maynard JA. mBio; 2022 Aug 30; 13(4):e0152722. PubMed ID: 35920558 [Abstract] [Full Text] [Related]
5. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Orr B, Douce G, Baillie S, Parton R, Coote J. Vaccine; 2007 Jan 02; 25(1):64-71. PubMed ID: 16916566 [Abstract] [Full Text] [Related]
6. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. Wang X, Gray MC, Hewlett EL, Maynard JA. J Biol Chem; 2015 Feb 06; 290(6):3576-91. PubMed ID: 25505186 [Abstract] [Full Text] [Related]
7. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice. Boehm DT, Hall JM, Wong TY, DiVenere AM, Sen-Kilic E, Bevere JR, Bradford SD, Blackwood CB, Elkins CM, DeRoos KA, Gray MC, Cooper CG, Varney ME, Maynard JA, Hewlett EL, Barbier M, Damron FH. Infect Immun; 2018 Oct 06; 86(10):. PubMed ID: 30012638 [Abstract] [Full Text] [Related]
8. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. Arciniega JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SG, Onorato IM, Manclark CR, Burns DL. J Infect Dis; 1991 Jan 06; 163(1):135-42. PubMed ID: 1984460 [Abstract] [Full Text] [Related]
9. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough]. Rastawicki W, Smietańska K, Rokosz-Chudziak N, Jagielski M. Med Dosw Mikrobiol; 2013 Jan 06; 65(4):269-74. PubMed ID: 24730215 [Abstract] [Full Text] [Related]
10. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough]. Gürsel D, Aslan A, Sönmez C, Koturoğlu G, Cöplü N, Kurugöl Z, Aydemir S. Mikrobiyol Bul; 2012 Apr 06; 46(2):211-24. PubMed ID: 22639310 [Abstract] [Full Text] [Related]
11. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis. Oguchi K, Miyata A, Kazuyama Y, Noda A, Suzuki E, Watanabe M, Nakayama T. J Infect Chemother; 2015 Sep 06; 21(9):639-46. PubMed ID: 26134278 [Abstract] [Full Text] [Related]
12. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG. Infect Immun; 2006 Dec 06; 74(12):6797-805. PubMed ID: 16982827 [Abstract] [Full Text] [Related]
13. Review of the neutrophil response to Bordetella pertussis infection. Eby JC, Hoffman CL, Gonyar LA, Hewlett EL. Pathog Dis; 2015 Dec 06; 73(9):ftv081. PubMed ID: 26432818 [Abstract] [Full Text] [Related]
14. Western blot analysis of antibody responses of young infants to pertussis infection. Guiso N, Grimprel E, Anjak I, Bégué P. Eur J Clin Microbiol Infect Dis; 1993 Aug 06; 12(8):596-600. PubMed ID: 8223658 [Abstract] [Full Text] [Related]
15. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Nagel J, de Graaf S, Schijf-Evers D. Dev Biol Stand; 1985 Aug 06; 61():325-30. PubMed ID: 2872120 [Abstract] [Full Text] [Related]
16. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals. Khosravani A, Parker MC, Parton R, Coote J. Vaccine; 2007 May 30; 25(22):4361-7. PubMed ID: 17434242 [Abstract] [Full Text] [Related]
17. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q. Vaccine; 2012 Nov 06; 30(48):6897-902. PubMed ID: 22981763 [Abstract] [Full Text] [Related]
18. Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination. Farfel Z, Könen S, Wiertz E, Klapmuts R, Addy PA, Hanski E. J Med Microbiol; 1990 Jul 06; 32(3):173-7. PubMed ID: 2374155 [Abstract] [Full Text] [Related]
19. Phagocytosis of Bordetella pertussis incubated with convalescent serum. Mobberley-Schuman PS, Connelly B, Weiss AA. J Infect Dis; 2003 May 15; 187(10):1646-53. PubMed ID: 12721945 [Abstract] [Full Text] [Related]
20. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay. Marley PB, Wilson JV, Habel H, Blaskett A. Dev Biol Stand; 1985 May 15; 61():341-52. PubMed ID: 2872123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]